Caitong International Asset Management Co., Ltd
Position in NSRX — Nasus Pharma Ltd
CIK 1963355
HONG KONG, K3
Position in NSRX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$14
New position
Shares Held
4
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 10 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Caitong International Asset Management Co., Ltd holds $9,469,596 across 12 Drug Manufacturers - General names. NSRX ranks #11 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,347 | $6,413,352 | |
| 2 | MRK |
Merck & Co., Inc.
|
9,320 | $1,197,620 | |
| 3 | JNJ |
Johnson & Johnson
|
2,986 | $758,354 | |
| 4 | GSK |
GSK plc
|
10,104 | $529,651 | |
| 5 | NVS |
Novartis AG
|
1,799 | $281,939 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
4,485 | $258,425 | |
| 7 | OGN |
Organon & Co.
|
1,989 | $26,931 | |
| 8 | BIIB |
Biogen Inc.
|
14 | $3,024 |
All Filings in NSRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14 | 4 | Shares | Sole | 2026-08-05 | |
| No filing history on record for this holder in this stock. | ||||||